Metastatic Liver Cancer Clinical Trials

31 clinical trials for Metastatic Liver Cancer across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma — RECRUITING · PHASE1
• GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC — RECRUITING · PHASE1
• A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) — RECRUITING · PHASE2
• Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC — RECRUITING · PHASE1
• Streamlining Radioembolization for CCC and Metastatic Liver Cancer — RECRUITING
• Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases — RECRUITING
• Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases — RECRUITING · PHASE1
• Treat Primary and Metastatic Liver Tumors — WITHDRAWN
• Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures — TERMINATED · NA
• Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) — TERMINATED · PHASE1
• Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2) — WITHDRAWN · NA
• Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree — OTHER
• PDO/PDO-TIL/PDOTS for Drug Screen — OTHER
• Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures — COMPLETED
• Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy — OTHER · PHASE1
• Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma — TERMINATED · PHASE1
• Liver Transplantation for Unresectable GIST Liver Metastases — OTHER · NA
• ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma — COMPLETED · PHASE1
• Chemotherapy for Resectable Colorectal Liver Metastases — COMPLETED
• DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria — OTHER · NA
• Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium — WITHDRAWN · PHASE4
• ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer — OTHER · PHASE1
• Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma — TERMINATED · PHASE1
• Prospective Tumor Response Evaluation — TERMINATED
• Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases — WITHDRAWN · PHASE4
• Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer — COMPLETED · PHASE1
• Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body — COMPLETED · NA
• Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver — TERMINATED
• Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE — OTHER · PHASE2
• Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma — OTHER · NA

Refine this search